Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium

NCT03158311 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1426

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: QVM149
DRUG: Salmeterol/fluticasone plus tiotropium

Sponsor

Novartis Pharmaceuticals